Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
Clinical trial NCT01857895 · COMPLETED
Trial details
- NCT number
- NCT01857895
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-16
- Primary completion
- 2013-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.